Sinovac Biotech Ltd
SVA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001084201
No open-market purchases or sales by Sinovac Biotech Ltd insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $224.9M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Sinovac Biotech Ltd changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 29 | 1 | 11 | −17 |
| Shares | 12.0M | 17 | 6.39M | −5.65M (−46.9%) |
| Value | $44.9M | $0 | $41.6M | −$3.26M (−7.3%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (2)
Institutions that held Sinovac Biotech Ltd at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| IFP Advisors, Inc | 18 | $8.00K | 0.00% |
| Sanders Morris Harris LLC | 2,000 | $0 | 0.00% |
Sold out (19)
Institutions that held Sinovac Biotech Ltd at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| State Street Corp | 281,640 | $1.82M |
| Renaissance Technologies LLC | 2,375,841 | $1.54M |
| Skandinaviska Enskilda Banken AB (publ) | 40,000 | $259.0K |
| Geode Capital Management, LLC | 27,717 | $179.0K |
| Susquehanna International Group, LLP | 16,430 | $106.0K |
| UBS Group AG | 9,095 | $59.0K |
| Northern Trust Corp | 13,787 | $55.0K |
| Morgan Stanley | 3,941 | $26.0K |
| JPMorgan Chase & Co | 3,000 | $19.0K |
| Northwestern Mutual Wealth Management Co | 102 | $1.00K |
| US Bancorp | 127 | $0 |
| Bank of America Corp | 126 | $0 |
| Wells Fargo & Company | 1,912 | $0 |
| Clearstead Advisors, LLC | 500 | $0 |
| Group One Trading, L.P. | 412 | $0 |
| Royal Bank of Canada | 516 | $0 |
| Spark Investment Management LLC | 29,100 | $0 |
| Advisor Group Holdings, Inc. | 1,362 | $0 |
| OrbiMed Advisors LLC | 2,839,500 | – |
Not filed for Q1 2022 yet (1)
Institutions that held Sinovac Biotech Ltd at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| NEXT Financial Group, Inc | 17 | $0 |